Bespoke Extracts (BSPK) Operating Leases (2022 - 2025)

Bespoke Extracts (BSPK) reported Operating Leases of $3805.0 for Q2 2025, down 98.45% on a YoY basis from $245335.0 in Q2 2024, and down 89.23% sequentially from $35345.0 in Q1 2025.

Bespoke Extracts (BSPK) Operating Leases (2022 - 2025) Analysis & Trends

Bespoke Extracts (BSPK) has 4 years of Operating Leases data on file, last reported at $3805.0 in Q2 2025.

  • For the quarter ending Q2 2025, Operating Leases fell 98.45% year-over-year to $3805.0; the trailing twelve-month figure through Jun 2025 stood at $3805.0 (down 98.45% YoY), and the FY2024 full-year result was $72504.0, down 51.81% from the prior year.
  • Operating Leases fell to $3805.0 in Q2 2025, from $35345.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $325498.0 in Q1 2022 to a low of $3805.0 in Q2 2025.
  • A 4-year average of $183924.6 and a median of $223735.0 in 2022 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases changed 0.0% in 2023 and slumped 98.45% in 2025, its largest moves.
  • Tracing BSPK's Operating Leases over 4 years: stood at $216039.0 in 2022, then tumbled by 30.36% to $150460.0 in 2023, then plunged by 51.81% to $72504.0 in 2024, then sank by 94.75% to $3805.0 in 2025.
  • Business Quant data shows BSPK's Operating Leases at $3805.0 in Q2 2025, $35345.0 in Q1 2025, and $72504.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Bespoke Extracts 1.12 Mn 1.11 Mn 234,175.00

Historic Data

Download Data
DateValue
Jun 30, 2025 3,805.00
Mar 31, 2025 35,345.00
Dec 31, 2024 72,504.00
Sep 30, 2024 90,138.00
Jun 30, 2024 245,335.00
Mar 31, 2024 133,652.00
Dec 31, 2023 150,460.00
Sep 30, 2023 231,431.00
Jun 30, 2023 247,907.00
Mar 31, 2023 264,219.00
Dec 31, 2022 216,039.00
Sep 30, 2022 310,704.00
Jun 30, 2022 247,907.00
Mar 31, 2022 325,498.00